A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Clinical trial NCT05551117 · TERMINATED

Trial details

NCT number: NCT05551117
Sponsor: MacroGenics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostatic Cancer Androgen-Independent Prostatic Cancer Androgen-Insensitive Prostatic Cancer Androgen-Resistant Prostatic Cancer Hormone Refractory Prostatic Cancer Anal Cancer Anal Neoplasm Carcinoma, Squamous Cell of Head and Neck Head and Neck Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma Oral Squamous Cell Carcinoma Malignant Melanoma

Start date: 2023-06-13
Primary completion: 2024-07-04
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.